1. Home
  2. NCNA vs YCBD Comparison

NCNA vs YCBD Comparison

Compare NCNA & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$1.31

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$0.46

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNA
YCBD
Founded
1997
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
6.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
NCNA
YCBD
Price
$1.31
$0.46
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
59.9K
350.5K
Earning Date
06-01-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.11
EPS
N/A
N/A
Revenue
N/A
$19,190,468.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.21
$0.41
52 Week High
$7.01
$2.56

Technical Indicators

Market Signals
Indicator
NCNA
YCBD
Relative Strength Index (RSI) N/A 44.91
Support Level N/A $0.46
Resistance Level N/A $0.53
Average True Range (ATR) 0.00 0.04
MACD 0.00 0.00
Stochastic Oscillator 0.00 32.94

Price Performance

Historical Comparison
NCNA
YCBD

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: